Verastem Oncology
VSTM
$9.98
Share price
0.00%
Change (1 day)
2,168.18%
Change (1 year)
Categories
Verastem Oncology (VSTM) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $92.34 M
According to Verastem Oncology 's latest financial reports the company's total liabilities are $92.34 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Verastem Oncology - Total liabilities on balance sheet (from 2011 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $47.65 M | 125.84% |
| 2021-12-31 | $21.1 M | -45.99% |
| 2020-12-31 | $39.07 M | -71.66% |
| 2019-12-31 | $0.13 B | -9.85% |
| 2018-12-31 | $0.15 B | 376.34% |
| 2017-12-31 | $32.1 M | 183.33% |
| 2016-12-31 | $11.33 M | 6.65% |
| 2015-12-31 | $10.62 M | 7.51% |
| 2014-12-31 | $9.88 M | 26.46% |
| 2013-12-31 | $7.81 M | 218.07% |
| 2012-12-31 | $2.45 M | -32.91% |
| 2011-12-31 | $3.66 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 148,488.97% | 🇺🇸 USA |
 LabCorp LH | $8.83 B | 9,467.05% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.82 B | 63,602.35% | 🇬🇧 UK |
 Curis CRIS | $57.61 M | -37.61% | 🇺🇸 USA |